Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Scynexis Inc (SCYX)  
$1.43 0.04 (2.52%) as of 4:30 Wed 3/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 23,951,000
Market Cap: 34.13(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.4 - $3.67
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   SCYNEXIS is a biotechnology company. Co. is developing its main product candidate, ibrexafungerp, as an intravenous/oral agent for multiple fungal indications in both the community and hospital settings. The U.S. Food and Drug Administration has approved BREXAFEMME (ibrexafungerp tablets) for treatment of patients with vulvovaginal candidiasis, also known as vaginal yeast infection, and Co. has commenced the commercialization of BREXAFEMME in the U.S. Co. also is continuing late-stage clinical development of ibrexafungerp for multiple indications, including the treatment of invasive fungal infections caused by Candida spp. (including C. auris) and Aspergillus spp. in hospitalized patients.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 78,500
Total Buy Value $0 $0 $0 $235,500
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 132
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Sukenick Scott Chief Legal Officer   •       –      –    2024-02-16 4 D $1.63 $24,742 D/D (15,179) 336,195     -
   Angulo Gonzalez David Chief Executive Officer   •       •      –    2024-01-26 4 A $0.00 $0 D/D 290,590 479,871     -
   Sukenick Scott Chief Legal Officer   •       –      –    2024-01-26 4 A $0.00 $0 D/D 143,675 351,374     -
   Macleod Ivor Chief Financial Officer   •       –      –    2024-01-26 4 A $0.00 $0 D/D 143,675 160,185     -
   Gilman Steven C   •       •      –    2023-06-15 4 A $0.00 $0 D/D 10,000 24,000     -
   Tinmouth Brian Philippe   •       •      –    2023-06-15 4 A $0.00 $0 D/D 10,000 28,000     -
   Anido Armando   •       •      –    2023-06-15 4 A $0.00 $0 D/D 10,000 25,000     -
   Macdonald Guy   •       •      –    2023-06-15 4 A $0.00 $0 D/D 10,000 32,000     -
   Hanham Ann   •       •      –    2023-06-15 4 A $0.00 $0 D/D 10,000 23,622     -
   Hastings David C   •       •      –    2023-06-15 4 A $0.00 $0 D/D 10,000 23,183     -
   Sukenick Scott Chief Legal Officer   •       –      –    2023-05-15 4 A $0.00 $0 D/D 50,000 203,599     -
   Sukenick Scott General Counsel   •       –      –    2023-01-27 4 A $0.00 $0 D/D 100,000 153,599     -
   Angulo Gonzalez David Chief Executive Officer   •       –      –    2023-01-01 4 A $0.00 $0 D/D 110,000 185,181     -
   Macleod Ivor Chief Financial Officer   •       –      –    2022-10-24 4 A $0.00 $0 D/D 15,000 15,000     -
   Anido Armando Director   –       •      –    2022-06-17 4 A $0.00 $0 D/D 10,000 15,000     -
   Hanham Ann Director   –       •      –    2022-06-17 4 A $0.00 $0 D/D 10,000 13,622     -
   Gilman Steven C Director   –       •      –    2022-06-17 4 A $0.00 $0 D/D 10,000 14,000     -
   Tinmouth Brian Philippe Director   –       •      –    2022-06-17 4 A $0.00 $0 D/D 10,000 18,000     -
   Hastings David C Director   –       •      –    2022-06-17 4 A $0.00 $0 D/D 10,000 13,183     -
   Macdonald Guy Director   –       •      –    2022-06-17 4 A $0.00 $0 D/D 10,000 22,000     -
   Taglietti Marco Chief Executive Officer   •       •      –    2022-04-26 4 B $3.00 $225,000 D/D 75,000 272,068 2.81 2%     
   Sukenick Scott General Counsel   •       –      –    2022-04-26 4 B $3.00 $10,500 D/D 3,500 53,499 2.74 2%     
   Taglietti Marco Chief Executive Officer   •       •      –    2022-02-04 4 A $0.00 $0 D/D 87,200 196,968     -
   Angulo Gonzalez David Chief Medical Officer   •       –      –    2022-02-04 4 A $0.00 $0 D/D 51,100 74,981     -
   Sukenick Scott General Counsel   •       –      –    2022-02-04 4 A $0.00 $0 D/D 40,700 49,899     -

  132 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed